FDA enforcement records identify Atrium Medical Corporation of Merrimack, New Hampshire, as the recalling firm for three Class II device recalls of Getinge PVC Thoracic Catheters, all tied to event 99680. The records describe soft PVC straight, firm PVC straight and soft PVC right-angle configurations, each packaged ten per case and listed with model numbers, UDI-DIs and lot numbers. The stated reason is an out-of-specification bacterial endotoxin test result in a single lot of catheters. [1][2][3]
Documented catheter configurations
The soft PVC straight catheter record lists five sizes: 16FR (8016), 24FR (8024), 28FR (8028), 32FR (8032) and 36FR (8036), each with a distinct UDI-DI and specified lot numbers. The firm PVC straight record covers 28FR (15028) and 36FR (15036). The soft PVC right-angle record covers 24FR (8124), 28FR (8128), 32FR (8132) and 36FR (8136). All three are described as ten per case. [1][2][3]
Recall scope and quantities
FDA lists 3,618 units for the soft PVC straight catheter, 256 units for the firm PVC straight catheter and 2,533 units for the soft PVC right-angle catheter. Each record carries Class II classification, voluntary firm-initiated status and an ongoing status, with a recall initiation date of August 7, 2026 and a center classification date of September 4, 2026. Distribution is described as US nationwide. [1][2][3]
The FDA recall database returns three results for event 99680, matching the three product records. A separate FDA recall page for the Getinge PVC Thoracic Catheter carries the Class 2 designation, and an FDA recall feed entry dated September 5, 2026 names Atrium Medical Corporation and the Getinge PVC Thoracic Catheter, Firm PVC Straight. [4][5][9]
Stated reason and third-party summaries
The reason given in each enforcement record is an out-of-specification result related to bacterial endotoxin testing in a single lot of catheters. Recall Canary, summarizing the FDA notice, describes the catheters as not meeting quality limits in a bacterial endotoxin test and rates the recall as moderate risk. Arca records the same recall as Class II, started August 7, 2026, voluntary and firm initiated, ongoing, with three products in the event. [1][7][8]
DeviceWatch, drawing on openFDA data, reports 6,024 adverse event reports naming Atrium Medical Corporation as device manufacturer, including 85 deaths, 4,965 injuries and 950 malfunctions, and states that its summaries and signals are provisional and require human review. Those figures describe reports naming the manufacturer and are not a measure of product safety performance. [10]
Identity and brand attribution
The product descriptions use the Getinge name, while the recalling firm in the FDA records is Atrium Medical Corporation. The records do not establish a corporate relationship between the two names beyond that product labeling, and no headquarters, ownership or website information is documented here; the Merrimack, New Hampshire address is the FDA filing address. [1][2][3]

